Member Comments are provided by individuals and reflect their personal opinions only. Under NO circumstances should you act on any advice or opinion posted in this forum.  ALWAYS check with your personal physician before taking any action regarding your health! MedHelp International and our partners, sponsors and affiliates have no obligation to monitor any comments posted on this site, or the content and/or accuracy of such exchanges. MedHelp International does not endorse the views of any user.
Neurology  (Expert Forum)
 | 
Re: CMT Type V
This forum is for questions and support regarding neurology issues such as: Alzheimer's Disease, ALS, Autism, Brain Cancer, Cerebral Palsy, Chronic Pain, Epilepsy, Fibromyalgia, Headaches, MS, Neuralgia, Neuropathy, Parkinson's Disease, RSD, Sleep Disorders, Stroke, Traumatic Brain Injury.

Re: CMT Type V

by CF-neurology, Jan 01, 1995 12:00AM
Posted By CCF neurology* on April 04, 1998 at 01:39:44:

In Reply to: CMT Type V posted by HM on April 02, 1998 at 20:39:38:






I have been diagnosed with Charcot-Marie-Tooth Type V (with spasticity).
I can find information on all CMT's except Type V.
Can you help, please?
Dear Hm,
CMT V is a disorder referred to as a hereditary motor and sensory neuropathy. It is characterized by peroneal muscle wasting and pyramidal signs.  Onset is usually before age 20 years. The patient usually presents with difficulty walking.  The syndrome clinically resembles CMT Types I and II with distal wasting and weakness involving the legs more than the arms.  The tendon reflexes in the arms and knees tend to  be increased (pyramidal sign) but are absent at the ankles. There tends to be increased stiffness (spascticty--also a pyramidal sign) and weakness in the proximal muscles (shoulders/thigh muscles) in 30% of patients. The disorder is hereditary (autosomal dominant) therefore, other members of the family should have the disorder as well. In general, it is slowly progressive and tends not to lead to severe disability. Good Luck.
Continue discussion
RSS Expert Activity
EVIDENCE-BASED APPROACH TO NEUTER S...
Dec 15 by Arnold L Goldman, D.V.M.
HOW DO/SHOULD DOCTORS THINK ABOUT T...
Dec 15 by Arnold L Goldman, D.V.M.
Simple tool to Assess your Risk for...
Dec 14 by Lee Kirksey, MD